EdiGene Inc. Employee Directory
Biotechnology ResearchBeijing, China11-50 Employees
EdiGene Inc. is a clinical-stage biotechnology company based in Beijing, China, focused on translating gene-editing technology into therapies for patients with significant unmet medical needs. It combines gene-editing capabilities, bioinformatics, and high-throughput screening to advance its pipeline. The company pursues therapeutic approaches that include in vivo RNA editing and ex vivo cell-editing strategies intended to treat genetic diseases and cancer. As a player in the biotechnology research industry, EdiGene is positioned to develop genetic medicines for patients, with collaborations and partnerships aiding translational efforts. In April 2023, the company announced an oral presentation of preclinical data in a non-human primate model for LEAPER 2.0-based in vivo RNA editing therapies at the ASGCT annual meeting. The organization maintains a small to mid-sized team.